Efficacy and safety of atorvastatin 10 mg every other day in hypercholesterolemia

Journal of the Medical Association of Thailand

Volumn 85, Issue 3, 2002, Pages 297-300

  Piamsomboon, Chumpol ^a   Saguanwong, Sopon ^a   Nasawadi, Chanarong ^a   Pongsiri, Kittika ^a   Lathavorn, Prasart ^a   Chatlaong, Boonsert ^b   Tanprasert, Pravit ^a  

^a PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^b Saint Loius Hospital   (Thailand)

Author keywords

Atorvastatin; Efficacy; Hypercholesterolemia

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIET THERAPY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; SOMNOLENCE; TREATMENT OUTCOME;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PYRROLES;

EID: 0036342240     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
2. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels
3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival study (4S)
4. The effect of pravastatin on coronary events after myocardial infarction inpatients with average cholesterol levels
5. Current perspectives on statins
6. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)
7. Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia
8. A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia
9. Effect of age and gender on pharmacokinetics of atorvastatin in humans
10. Reduction of LDL cholesterol by 25 per cent to 60 per cent in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor
11. Hypocholesterolemic actions of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig